Table 2.

Clinical characteristics of 47 systemic sclerosis patients.

Disease duration, years	12.70 (SD 9.52), min–max (1–40)
Rodnan skin thickness score	13.30 (SD 7.21), min–max (2–30)
Subtype of systemic sclerosis
Limited nr, %	35, 74.5%
Diffuse nr, %	12, 25.5%
Capillaroscopy evaluation
Active nr, %	17, 36.2%
Late nr, %	20, 42.6%
Early nr, %	10, 21.3%
Treatment during the last half a year
ACE inhibitors nr, %	8, 17.0%
Calcium channels blockers nr, %	37, 78.7%
Methotrexate nr, %	8, 17.0%
Azathioprine nr, %	8, 17.0%
Antimalarials nr, %	5, 10.64%
Steroids nr, %	23, 48.94%